LINDSTROM RICHARD L MD
SEC CIK 1242177 · EDGAR
BoughtSold
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 17:20 | 2026-06-10 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +14.0K | 260.9K | +6% | $0 |
| 2026-06-05 17:30 | 2026-06-03 | LNSR | LENSAR, Inc. | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +17.4K | 263.8K | +7% | $0 | |
| 2026-02-24 | 2026-02-20 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | P - Purchase | $7.66 | +60.2K | 246.9K | +32% | +$461.4K | |
| D | 2025-06-13 | 2025-06-11 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +14.0K | 143.1K | +11% | $0 |
| 2025-05-28 | 2025-05-23 | LNSR | LENSAR, Inc. | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +7,374 | 246.4K | +3% | $0 | |
| 2025-05-12 | 2025-05-08 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | P - Purchase | $6.96 | +10.0K | 172.7K | +6% | +$69.6K | |
| DM | 2024-07-26 | 2024-02-27 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | M - OptEx | $8.80 | +30.3K | 150.7K | +25% | +$266.7K |
| D | 2024-07-26 | 2024-07-24 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +12.0K | 162.7K | +8% | $0 |
| 2024-05-09 | 2024-05-07 | LNSR | LENSAR, Inc. | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +22.0K | 239.0K | +10% | $0 | |
| D | 2023-06-16 | 2023-06-14 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +12.0K | 120.4K | +11% | $0 |
| D | 2023-05-30 | 2023-05-25 | LNSR | LENSAR, Inc. | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +9,288 | 217.0K | +4% | $0 |
| I | 2022-10-03 | 2022-09-30 | HROW | HARROW, INC. | LINDSTROM RICHARD L MD | Dir | S - Sale | $12.62 | -40.0K | 26.1K | -61% | -$504.8K |
| D | 2022-06-21 | 2022-06-16 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +8,933 | 108.4K | +9% | $0 |
| D | 2022-05-27 | 2022-05-25 | LNSR | LENSAR, Inc. | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +4,285 | 207.7K | +2% | $0 |
| D | 2022-05-16 | 2022-05-12 | OCUL | OCULAR THERAPEUTIX, INC | LINDSTROM RICHARD L MD | Dir | M - OptEx | $1.22 | +9,469 | 99.5K | +11% | +$11.6K |
| I | 2021-09-27 | 2021-09-24 | HROW | HARROW, INC. | LINDSTROM RICHARD L MD | Dir | S - Sale | $10.04 | -3,900 | 66.1K | -6% | -$39.2K |
| MI | 2021-09-17 | 2021-09-15+ | HROW | HARROW, INC. | LINDSTROM RICHARD L MD | Dir | S - Sale | $9.07 | -20.0K | 75.8K | -21% | -$181.4K |
Purchase Sale Sale after option exercise All abbreviations